SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001664710-23-000050
Filing Date
2023-08-07
Accepted
2023-08-07 08:04:53
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kros-20230630.htm   iXBRL 10-Q 1093301
2 EX-31.1 exhibit311q22023.htm EX-31.1 17233
3 EX-31.2 exhibit312q22023.htm EX-31.2 17114
4 EX-32.1 exhibit321q22023.htm EX-32.1 9845
10 kros-20230630_g1.jpg GRAPHIC 32596
11 kros-20230630_g2.jpg GRAPHIC 31788
12 kros-20230630_g3.jpg GRAPHIC 94931
  Complete submission text file 0001664710-23-000050.txt   4558706

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20230630.xsd EX-101.SCH 27723
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kros-20230630_cal.xml EX-101.CAL 47873
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kros-20230630_def.xml EX-101.DEF 89684
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20230630_lab.xml EX-101.LAB 442976
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20230630_pre.xml EX-101.PRE 262534
51 EXTRACTED XBRL INSTANCE DOCUMENT kros-20230630_htm.xml XML 300579
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39264 | Film No.: 231145716
SIC: 2834 Pharmaceutical Preparations